Clinical Trial Update: Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Thymosin in combination with PEG-Interferon in hepatitis C patients with cirrhosis who did not respond to interferon or interf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Peg-interferon (pegylated interferon alfa)
• Thymosin (thymosin alpha-1)

Snippet

Sponsor: SciClone Pharmaceuticals | Conditions: Hepatitis C, Hepatitis C, Chronic | Phase 3 | Status: COMPLETED